Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
CNY 32.73
(2.22%)
CNY 32.73
(2.22%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.2 Billion CNY | 27.22% |
| 2022 | 1.73 Billion CNY | -3.1% |
| 2021 | 1.78 Billion CNY | 2.41% |
| 2020 | 1.74 Billion CNY | -3.1% |
| 2019 | 1.8 Billion CNY | 14.28% |
| 2018 | 1.57 Billion CNY | 16.52% |
| 2017 | 1.35 Billion CNY | 11.94% |
| 2016 | 1.2 Billion CNY | 1.42% |
| 2015 | 1.19 Billion CNY | 10.76% |
| 2014 | 1.07 Billion CNY | 10.45% |
| 2013 | 973.73 Million CNY | 19.49% |
| 2012 | 814.91 Million CNY | 32.9% |
| 2011 | 613.18 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 685.83 Million CNY | 4.6% |
| 2024 Q1 | 655.66 Million CNY | -4.11% |
| 2024 Q3 | 600.04 Million CNY | -12.51% |
| 2023 Q3 | 477.03 Million CNY | -18.13% |
| 2023 Q2 | 582.65 Million CNY | 22.22% |
| 2023 Q1 | 476.74 Million CNY | -18.92% |
| 2023 FY | 2.2 Billion CNY | 27.22% |
| 2023 Q4 | 683.78 Million CNY | 43.34% |
| 2022 Q4 | 588.01 Million CNY | 80.09% |
| 2022 Q3 | 326.52 Million CNY | -24.85% |
| 2022 Q1 | 382.67 Million CNY | -41.07% |
| 2022 Q2 | 434.5 Million CNY | 13.54% |
| 2022 FY | 1.73 Billion CNY | -3.1% |
| 2021 Q3 | 263.91 Million CNY | -43.81% |
| 2021 FY | 1.78 Billion CNY | 2.41% |
| 2021 Q1 | 404.11 Million CNY | -33.5% |
| 2021 Q2 | 469.68 Million CNY | 16.22% |
| 2021 Q4 | 649.31 Million CNY | 146.03% |
| 2020 Q2 | 423.36 Million CNY | 14.31% |
| 2020 Q3 | 343.57 Million CNY | -18.85% |
| 2020 FY | 1.74 Billion CNY | -3.1% |
| 2020 Q4 | 607.69 Million CNY | 76.88% |
| 2020 Q1 | 370.35 Million CNY | -37.15% |
| 2019 Q3 | 396.73 Million CNY | -11.85% |
| 2019 Q1 | 364.79 Million CNY | -29.86% |
| 2019 FY | 1.8 Billion CNY | 14.28% |
| 2019 Q4 | 589.26 Million CNY | 48.53% |
| 2019 Q2 | 450.06 Million CNY | 23.38% |
| 2018 Q2 | 393.48 Million CNY | 17.44% |
| 2018 FY | 1.57 Billion CNY | 16.52% |
| 2018 Q4 | 520.1 Million CNY | 58.99% |
| 2018 Q3 | 327.12 Million CNY | -16.87% |
| 2018 Q1 | 335.04 Million CNY | 0.0% |
| 2017 FY | 1.35 Billion CNY | 11.94% |
| 2016 FY | 1.2 Billion CNY | 1.42% |
| 2015 FY | 1.19 Billion CNY | 10.76% |
| 2014 FY | 1.07 Billion CNY | 10.45% |
| 2013 FY | 973.73 Million CNY | 19.49% |
| 2012 FY | 814.91 Million CNY | 32.9% |
| 2011 FY | 613.18 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Liuzhou Liangmianzhen Co., Ltd. | 995.13 Million CNY | -121.386% |
| Shanghai Jahwa United Co., Ltd. | 6.55 Billion CNY | 66.374% |
| Henan Rebecca Hair Products Co., Ltd. | 1.22 Billion CNY | -79.762% |
| Perfect Group Corp., Ltd | 1.06 Billion CNY | -106.564% |
| RUNBEN BIOTECHNOLOGY | 1.03 Billion CNY | -113.281% |
| Proya Cosmetics Co.,Ltd. | 8.9 Billion CNY | 75.259% |
| Lafang China Co.,Ltd | 859.78 Million CNY | -156.237% |
| Shanghai Flyco Electrical Appliance Co., Ltd. | 5.05 Billion CNY | 56.458% |
| Hangzhou Haoyue Personal Care Co., Ltd | 2.75 Billion CNY | 20.088% |